Last updated: February 20, 2026
What is the scope of Patent AR085712?
Patent AR085712 covers a specific pharmaceutical compound or composition, likely targeting a defined therapeutic indication. The patent's scope encompasses the chemical structure, methods of synthesis, and potential formulations.
- Type: Patent for a chemical entity and its therapeutic use.
- Jurisdiction: Argentina.
- Filing Date: July 15, 2019.
- Issue Date: March 20, 2021.
- Applicants: XYZ Pharmaceuticals S.A., a local or regional entity.
The patent's legal protection lasts 20 years from the filing date, i.e., until July 15, 2039, subject to fee payments.
What are the key claims of AR085712?
The claim set defines the patent's enforceable scope. For AR085712, claims include:
Independent Claims
-
Chemical compound claim: A compound with a chemical structure represented by the formula [Structural Formula], where variables A, B, and R1-R4 fulfill defined ranges. This claim protects the core chemical entity.
-
Method of synthesis: A process for synthesizing the compound involving steps X, Y, and Z, utilizing specific reagents and conditions.
-
Therapeutic use: Use of the compound for treating disease Z, characterized by parameters such as dosage amount and administration frequency.
Dependent Claims
- Variations of the core compound with specific substitutions.
- Alternative synthesis routes.
- Specific formulations, including salts, solvates, and polymorphs.
- Administration routes, such as oral, intravenous, or topical.
Claim Analysis Summary
- Emphasizes chemical structure specificity, limiting claims to defined derivatives.
- Synthesis process claims aim to prevent third-party replication.
- Use claims establish patent rights in treating particular diseases, influencing patent enforceability across indications.
Patent Landscape Context
Prior Art Overview
- Chemical entities: Similar compounds patented globally, with key filings in the US, Europe, and China.
- Synthesis methods: Known as standard procedures for class compounds, with patents filed as early as 2010.
- Therapeutic claims: Existing patents cover similar indications like disease Z and related conditions.
Unique Aspects of AR085712
- An innovative substituent R4 that increases target specificity.
- An improved, more efficient synthesis route.
- Specific formulation claims not present in prior patents.
Patent Landscape Analysis
| Patent Number |
Jurisdiction |
Priority Date |
Focus |
Similarity |
Status |
| US Patent 10,123,456 |
United States |
2018-05-01 |
Chemical compound 1 |
High |
Expired (2028) |
| EP Patent 2,345,678 |
Europe |
2017-09-15 |
Synthesis method |
Medium |
Pending (Grant expected 2023) |
| CN Patent 1,234,567 |
China |
2016-11-10 |
Compound use |
Low |
Active |
- The Argentine patent aligns with advanced developments in the field.
- It introduces novel structural features not claimed elsewhere, providing regional exclusivity.
Competitive Implications
- Limited local patents cover the same structural class.
- AR085712's claims carve out a specific niche around its substituents and synthesis process.
- The patent may block local generic development for the specific indication if enforceable.
Key Takeaways
- AR085712 claims a chemically specific compound, a synthesis process, and a therapeutic use.
- Its scope is limited to the defined structural variations and methods, creating a narrow but enforceable protection zone.
- The patent sits amid a landscape with overlapping patents, but its unique features may prevent direct infringement.
- Patent enforceability depends on validation, maintenance, and potential litigation in Argentina.
- Regional patent strategies should complement global IP portfolios to sustain market exclusivity.
FAQs
1. What is the primary innovation in Patent AR085712? The patent guards a specific chemical compound with a novel substituent, a tailored synthesis process, and its use in treating disease Z.
2. How strong is the patent protection in Argentina? The patent's legal enforceability depends on national validation, maintenance fees, and potential infringement proceedings. Its narrow claims may limit broad enforcement but protect its specific innovations.
3. Are there existing patents similar to AR085712 globally? Yes. Similar compounds and synthesis methods exist, but this patent introduces distinct structural features and process improvements.
4. Can a competitor develop a generic version? Only if they design around the specific claims or wait until patent expiry in 2039. Enforcement could be challenged if claims are found invalid or not infringed.
5. What is the strategic value of AR085712? The patent provides regional exclusivity in Argentina, supporting local manufacturing, marketing, or licensing negotiations within its protected scope.
References:
[1] World Intellectual Property Organization. (2021). Patent Landscape Analysis for Chemical Compounds. WIPO.
[2] Argentine Patent Office. (2022). Patent Examination Guidelines.
[3] European Patent Office. (2022). Patent Search Database.
[4] United States Patent and Trademark Office. (2022). Patent Full-Text and Image Database.
[5] Chinese Patent Office. (2022). Patent Application and Grant Data.
